Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Human Genetics : EJHG|September 19, 2019
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet databaseStéphanie Nguengang Wakap, Deborah M Lambert, Annie Olry, et al.
Hepatology Communications|November 6, 2023
Predicting hepatic encephalopathy in patients with cirrhosis: A UK population-based study and validation of risk scoresBethan I Jones, Cerys A Jenkins, Daniel Murphy, et al.
HIV Clinical Trials|November 9, 2012
ARIES 144 week results: durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudineKathleen E Squires, Benjamin Young, Edwin DeJesus, et al.
The Science of the Total Environment|November 12, 2023
Advancing PFAS characterization: Enhancing the total oxidizable precursor assay with improved sample processing and UV activationDavid Patch, Natalia O'Connor, Taylor Vereecken, et al.
Echo Research and Practice|June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UKNina Karia, Daniel Murphy, Luke Howard, et al.
AIDS (London, England)|July 9, 2010
Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patientsKathleen E Squires, Benjamin Young, Edwin Dejesus, et al.
Scientific Reports|December 6, 2017
CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivityJosephine B Walton, Malcolm Farquharson, Susan Mason, et al.
Plos One|March 4, 2014
HIV-1 transmission patterns in antiretroviral therapy-naïve, HIV-infected North Americans based on phylogenetic analysis by population level and ultra-deep DNA sequencingLisa L Ross, Joseph Horton, Samiul Hasan, et al.
Scientific Reports|April 14, 2018
Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivityJosephine B Walton, Malcolm Farquharson, Susan Mason, et al.
Annals of Internal Medicine|August 2, 2016
Trends in Prevalence of Chronic Kidney Disease in the United StatesDaniel Murphy, Charles E McCulloch, Feng Lin, et al.
Pageof 8